SHaRE Registry
Enrolling By Invitation
99 years and younger
All
Phase
N/A
1 Location
Brief description of study
This study aims to identify genotypic and phenotypic characteristics that are
associated with the clinical heterogeneity and outcomes of hypertrophic
cardiomyopathy (HCM), using the Sarcomeric Human Cardiomyopathy
Registry (SHaRe).
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: - 99 Years
-
Gender: All
TBD
Updated on
01 Aug 2024.
Study ID: 850703
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com
